Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 20, 2019
Plasminogen activator inhibitor 1 in acute coronary syndromesMarin Pavlov, Ivana Ćelap
Biochemia Medica|October 22, 2024
Glucose inhibitor tubes in Croatian laboratories: are we doing well?Alen Vrtarić, Nora Nikolac Gabaj, Ivana Ćelap
Biochemia Medica|February 18, 2020
Analytical verification and comparison of chromogenic assays for dabigatran, rivaroxaban and apixaban determination on BCSXP and STA Compact Max analysersIvana Ćelap, Sandra Margetić, Marija Brčić, et al.
Biochemia Medica|December 1, 2017
Corrigendum to: Minimum requirements for the estimation of the measurement uncertainty: Recommendations of the joint Working group for uncertainty of measurement of the CSMBLM and CCMBIvana Ćelap, Ines Vukasović, Gordana Juričić, et al.
Biochemia Medica|November 29, 2017
Minimum requirements for the estimation of measurement uncertainty: Recommendations of the joint Working group for uncertainty of measurement of the CSMBLM and CCMBIvana Ćelap, Ines Vukasović, Gordana Juričić, et al.
Acta Pharmaceutica (Zagreb, Croatia)|January 18, 2023
Direct oral anticoagulants (DOACs): From the laboratory point of viewSandra Margetić, Sandra Šupraha Goreta, Ivana Ćelap, et al.
Molecular Biology Reports|November 7, 2014
Serotonin transporter polymorphism (5-HTTLPR) in Croatian populationJelena Culej, Mario Štefanović, Ivana Ćelap, et al.
Laboratory Medicine|October 5, 2019
α-1 Antitrypsin Genotype-Phenotype Discrepancy in a 42-Year-Old Man Who Carries the Null-AlleleTomislav Pavičić, Ivana Ćelap, Milena Njegovan, et al.
Biochemia Medica|June 28, 2016
Interference of M-protein on prothrombin time test - case reportSandra Margetić, Ivana Ćelap, Lora Dukić, et al.
World Journal of Diabetes|August 27, 2020
Sodium-glucose cotransporter 2 inhibitors' mechanisms of action in heart failurePetra Grubić Rotkvić, Maja Cigrovski Berković, Nikola Bulj, et al.
Pageof 3